Published Date: 08 Mar 2023
A study presented at the American College of Cardiology Annual Review showed that a wrist-worn test predicted troponin-I and occluded arteries with 90% accuracy within 5 minutes.
Read Full NewsOne study compared cost-effectiveness between treatments, the other mortality rates and other long-term outcomes for GLP1-s versus SGLT2 inhibitors.
Mirum Pharmaceuticals said on Monday its experimental drug, volixibat, met the main goal of a mid-stage study by reducing severe itching or pruritus in patients with a...
Eating more fiber, especially soluble fiber, may significantly reduce the risk for dementia among older adults, results of a large, long-term observational study show.
Crisugabalin reduced pain and improved sleep, mood, and quality of life vs placebo in patients with central neuropathic pain.
A real-world study assesses survival outcomes when adding PD-1 inhibitors to asparaginase-based regimens in patients with extranodal natural killer/T-cell lymphoma.
A 5-day course of amoxicillin is the most prescribed antibiotic treatment for children with acute otitis media at the Finnish hospitals studied, indicating high adherence to national guidelines.
Handgrip strength correlates with disease activity, health-related quality of life, and depression in patients with inflammatory bowel disease.
1.
Unlocking the potential of targeted therapies for multiple myeloma
2.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
3.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
4.
Can Prior Authorization Be Better With Artificial Intelligence?
5.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
The Power of Romiplostim in Treating Low Platelet Counts
3.
Examining Serum Osmolality: What It Is And How To Test For It
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation